An Overview of the Natural History of Inflammatory Bowel Diseases
暂无分享,去创建一个
[1] J. Mary,et al. Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. , 2013, Gastroenterology.
[2] C. J. van der Woude,et al. Phenotype of Inflammatory Bowel Disease at Diagnosis in the Netherlands: A Population-based Inception Cohort Study (the Delta Cohort) , 2013, Inflammatory bowel diseases.
[3] L. Greco,et al. Periappendiceal Inflammation in Pediatric Ulcerative Colitis , 2013, Inflammatory bowel diseases.
[4] E. Cabré,et al. Does active smoking really influence the course of Crohn's disease? A retrospective observational study. , 2013, Journal of Crohn's & colitis.
[5] H. Sokol,et al. Long-term outcome of patients with Crohn's disease who respond to azathioprine. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[6] G. Veres,et al. Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009 , 2012, The American Journal of Gastroenterology.
[7] E. Cabré,et al. Long-term outcome of ulcerative colitis in patients who achieve clinical remission with a first course of corticosteroids. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[8] J. Cotter,et al. Review of the disease course among adult ulcerative colitis population‐based longitudinal cohorts , 2012, Inflammatory bowel diseases.
[9] E. Cabré,et al. Long-term outcome of patients with distal ulcerative colitis and inflammation of the appendiceal orifice. , 2011, Journal of gastrointestinal and liver diseases : JGLD.
[10] Geraint T. Williams,et al. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates , 2010, Gut.
[11] P. Munkholm,et al. Overall and cause‐specific mortality in Crohn's disease: A meta‐analysis of population‐based studies , 2009, Inflammatory bowel diseases.
[12] E. Cabré,et al. Top-Down Therapy: Is the Evidence Strong Enough? , 2009, Digestive Diseases.
[13] P. Dagnelie,et al. Influence of Phenotype at Diagnosis and of Other Potential Prognostic Factors on the Course of Inflammatory Bowel Disease , 2009, The American Journal of Gastroenterology.
[14] T. Ponich,et al. Predictive factors associated with immunosuppressive agent use in ulcerative colitis: a case–control study , 2008, Alimentary pharmacology & therapeutics.
[15] M. Vos,et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial , 2008, The Lancet.
[16] P. Munkholm,et al. Changes in Clinical Characteristics, Course, and Prognosis of Inflammatory Bowel Disease during the Last 5 Decades: A Population‐Based Study from Copenhagen, Denmark , 2007, Inflammatory bowel diseases.
[17] William J. Tremaine,et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.
[18] T. Sørensen,et al. Overall and Cause-Specific Mortality in Ulcerative Colitis: Meta-analysis of Population-Based Inception Cohort Studies , 2007, The American Journal of Gastroenterology.
[19] M. Vatn,et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. , 2007, Gastroenterology.
[20] M. Vatn,et al. Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study) , 2007, Scandinavian journal of gastroenterology.
[21] H. Drummond,et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5‐year UK inception cohort , 2006, Alimentary pharmacology & therapeutics.
[22] M. Vatn,et al. Ulcerative colitis and clinical course: Results of a 5‐year population‐based follow‐up study (the IBSEN study) , 2006, Inflammatory bowel diseases.
[23] D. Heresbach,et al. Wireless capsule endoscopy versus ileocolonoscopy for the diagnosis of postoperative recurrence of Crohn’s disease: a prospective study , 2006, Gut.
[24] J. Satsangi,et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[25] F. Carbonnel,et al. Long-Term Evolution of Disease Behavior of Crohn's Disease , 2002, Inflammatory bowel diseases.
[26] J. Belaiche,et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease , 2001, Gut.
[27] A. Zinsmeister,et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. , 2001, Gastroenterology.
[28] D. Jewell,et al. A Simple Classification of Crohn's Disease: Report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998 , 2000, Inflammatory bowel diseases.
[29] P. Rutgeerts,et al. Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study. , 1997, The American journal of gastroenterology.
[30] J. Colombel,et al. Perioperative endoscopy of the whole small bowel in Crohn's disease. , 1993, Gut.
[31] D. Sachar,et al. Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. , 1988, Gut.